Talabostat (PT-100) T-cell independent anti-tumor activity cooperates with pemetrexed and erlotinib in A549 non-small cell lung cancer (NSCLC) xenograft model.

被引：0
|
作者：
Adams, S [1 ]
Surman, M [1 ]
Jones, B [1 ]
机构：
[1] Point Therapeut Inc, Boston, MA USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9157S / 9157S
页数：1
相关论文
共 50 条
  • [41] Induction of Tertiary Lymphoid Structures in Non-Small Cell Lung Cancer Improves B and T Cell Anti-Tumor Immunity
    Kim, H. Mi
    Liu, D.
    Ruffin, A.
    McDonough, A.
    Lampenfeld, C.
    Kunning, S.
    Somasundaram, A.
    Stabile, L.
    Bruno, T.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E24 - E25
  • [42] INDUCTION OF TERTIARY LYMPHOID STRUCTURES IN NON-SMALL CELL LUNG CANCER IMPROVES B AND T CELL ANTI-TUMOR IMMUNITY
    Kim, Hye Mi
    Liu, Dongyan
    Ruffin, Ayana
    McDonough, Alexandra
    Lampenfeld, Caleb
    Kunning, Sheryl
    Somasundaram, Ashwin
    Stabile, Laura
    Bruno, Tullia
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1180 - A1180
  • [43] Concentration-dependent early anti-vascular and anti-tumor effects of itraconazole in non-small cell lung cancer (NSCLC)
    Gerber, David E.
    Fattah, Farjana J.
    Brekken, Rolf A.
    Skelton, Rachael
    Saltarski, Jessica
    Ahn, Chul
    Kernstine, Kemp H.
    Padmanabhan, Chyndhri
    Chemburkar, Vaidehi
    Kasiri, Sahba
    Kallem, Rajareddy
    Subramaniyan, Indhumathy
    Yuan, Qing
    Do, Quyen N.
    Xi, Yin
    Pedrosa, Ivan
    Putnam, William C.
    Kim, James
    CANCER RESEARCH, 2019, 79 (13)
  • [44] Hypoxia Modulates Radiosensitivity and Response to Different Radiation Qualities in A549 Non-Small Cell Lung Cancer (NSCLC) Cells
    Nisar, Hasan
    Labonte, Frederik M.
    Roggan, Marie Denise
    Schmitz, Claudia
    Chevalier, Francois
    Konda, Bikash
    Diegeler, Sebastian
    Baumstark-Khan, Christa
    Hellweg, Christine E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [45] Effect of GDC-0449, a hedgehog (Hh) pathway inhibitor, on tumor activity and on erlotinib and cisplatin in a xenograft model of non-small cell lung cancer (NSCLC) with activated Hh pathway.
    Ahmad, Aamir
    Sarkar, Fazlul H.
    Maitah, Main
    Ali, Shadan
    Sethi, Seema
    Aboukameel, Amro
    Gadgeel, Shirish M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [46] Anti-cancer effect of celecoxib and aerosolized docetaxel against human non-small cell lung cancer cell line, A549
    Fulzele, SV
    Shaik, MS
    Chatterjee, A
    Singh, M
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 (03) : 327 - 336
  • [47] Myricanol Induces Apoptotic Cell Death and Anti-Tumor Activity in Non-Small Cell Lung Carcinoma in Vivo
    Dai, Guanhai
    Tong, Yeling
    Chen, Xuan
    Ren, Zeming
    Ying, Xuhua
    Yang, Feng
    Chai, Kequn
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (02) : 2717 - 2731
  • [48] Comparative T-cell oligoclonality in lung, tumor and lymph nodes in human non-small cell lung cancer
    Derniame, S
    Vignaud, JM
    Faure, GC
    Béné, MC
    Massin, F
    ONCOLOGY REPORTS, 2005, 13 (03) : 509 - 515
  • [49] ANTITUMOR ACTIVITY OF BEVACIZUMAB IN COMBINATION WITH PEMETREXED AS MAINTENANCE THERAPY FOR NON-SMALL CELL LUNG CANCER IN A XENOGRAFT MODEL: COMPARISON WITH PEMETREXED MONOTHERAPY AND ANALYSIS OF THE COMBINATION MECHANISM
    Ishikura, Nobuyuki
    Yamamoto, Kaname
    Iwai, Toshiki
    Yorozu, Keigo
    Kurasawa, Mitsue
    Harada, Naoki
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S769 - S769
  • [50] SYNERGISTIC ANTITUMOR ACTIVITY OF BEVACIZUMAB AND ERLOTINIB IN EGFR-MUTATED NON-SMALL CELL LUNG CANCER XENOGRAFT MODELS
    Moriya, Yoichiro
    Yamamoto, Kaname
    Yanagisawa, Mieko
    Yorozu, Keigo
    Kurasawa, Mitsue
    Furugaki, Koh
    Iwai, Toshiki
    Ishikura, Nobuyuki
    Harada, Naoki
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S768 - S768
12345